153 related articles for article (PubMed ID: 22507948)
21. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.
Pozniak AL; Coyne KM; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB;
HIV Med; 2011 Oct; 12(9):517-24. PubMed ID: 21951595
[No Abstract] [Full Text] [Related]
22. TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?
Shastri S; Naik B; Shet A; Rewari B; De Costa A
BMC Public Health; 2013 Sep; 13():838. PubMed ID: 24025316
[TBL] [Abstract][Full Text] [Related]
23. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
24. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
Ige OM; Akindele MO
Afr J Med Med Sci; 2011 Mar; 40(1):15-21. PubMed ID: 21834257
[TBL] [Abstract][Full Text] [Related]
25. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study.
Zheng Z; Nehl EJ; Zhou C; Li J; Xie Z; Zhou Z; Liang H
BMC Infect Dis; 2020 Nov; 20(1):873. PubMed ID: 33225919
[TBL] [Abstract][Full Text] [Related]
26. Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
Chaisson RE; Clermont HC; Holt EA; Cantave M; Johnson MP; Atkinson J; Davis H; Boulos R; Quinn TC; Halsey NA
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1034-8. PubMed ID: 8887603
[TBL] [Abstract][Full Text] [Related]
27. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
Ifebunandu NA; Ukwaja KN; Obi SN
Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
[TBL] [Abstract][Full Text] [Related]
28. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
[TBL] [Abstract][Full Text] [Related]
29. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
30. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
[TBL] [Abstract][Full Text] [Related]
31. Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro.
Pacheco AG; Veloso VG; Nunes EP; Ribeiro S; Guimarães MR; Lourenço MC; Mello FC; Grinsztejn B
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1473-8. PubMed ID: 25517814
[TBL] [Abstract][Full Text] [Related]
32. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.
Severe P; Juste MA; Ambroise A; Eliacin L; Marchand C; Apollon S; Edwards A; Bang H; Nicotera J; Godfrey C; Gulick RM; Johnson WD; Pape JW; Fitzgerald DW
N Engl J Med; 2010 Jul; 363(3):257-65. PubMed ID: 20647201
[TBL] [Abstract][Full Text] [Related]
33. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
[TBL] [Abstract][Full Text] [Related]
34. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy.
Martín-Echevarria E; Serrano-Villar S; Sainz T; Moreno A; Casado JL; Dronda F; Elías MJ; Navas E; Zapata MR; Moreno S
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1080-4. PubMed ID: 25189556
[TBL] [Abstract][Full Text] [Related]
35. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
[TBL] [Abstract][Full Text] [Related]
37. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
[TBL] [Abstract][Full Text] [Related]
38. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
Gray DM; Workman LJ; Lombard CJ; Jennings T; Innes S; Grobbelaar CJ; Cotton MF; Zar HJ
Int J Tuberc Lung Dis; 2014 Mar; 18(3):322-7. PubMed ID: 24670570
[TBL] [Abstract][Full Text] [Related]
40. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
